Nio Shares Surge After Launch of Chinas Largest Electric SUV Spacious Enough for Yao Ming UK Spy Chief Warns of Moment of Consequence as West Faces Mounting Threats from Russia and China US CPI Report for April 2026 Released TD Economics Provides Analysis Earnings Season Outlook Analyst Estimates and Key Stocks on the Radar US GDP Growth for Q1 2026 Revised Lower to 16 Amid Slowing Corporate Profits Is 2 Million Enough for Retirement Key Factors That Could Determine Savings Longevity Rockwell Medical Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges PH Q1 2026 Earnings EPS Surpasses Expectations Amid Tough Macro Headwinds RVMD Q1 2026 Earnings EPS Miss Signals Higher RD Spending Amid LateStage Pipeline Push OXSQG Q1 2026 Earnings EPS Misses Estimates as Notes Decline Plexus Corp PLXS Q1 2026 Earnings Solid EPS Beat Partially Offset by Cautious Market Sentiment MNKD Q1 2026 Earnings Significant EPS Miss Overshadowed by Stock Rally Quantumsphere Acquisition Units Edge Lower as Consolidation Persists Near Support Huron Consulting Group HURN Slips 148 as Shares Approach Critical Support Zone Novartis NVS Holds Steady Near Resistance as Trading Volume Remains Subdued Shinhan Financial Group SHG Slides 230 as Banking Sector Headwinds Mount Sizzle Acquisition Corp II Rights SZZLR Trading at 016 Navigating a Narrow Range Korea Post Diversifies Into AI Data Centres and Real Estate to Offset Mounting Mail Losses Citi Highlights Two Catalysts That Could Drive SanDisk Stock Higher Blast Targeting Military Train in Pakistan Could Heighten Security Concerns for Investors SNC Scandic Coin Lists on Major Exchanges as Regulated RealWorld Asset Project Taylor Swifts Chart Dominance Stalled Ordinary Blocks The Fate of Ophelia for 12 Weeks on Adult Contemporary SAP SE Emerges as Top Tech Holding in Ken Fishers Portfolio Amid AI Agent Platform Launch AI Reshapes Labor Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Jobs Slow BCSF Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Edges Lower Aytu BioPharma Gains 164 as Stock Tests Key Resistance at 228